Regional Presence of a Proton Therapy Center: Imperative

A recent study “Proton Beam Therapy and Treatment for Localized Prostate Cancer: If You Build It, They Will Come” published in the JAMA Internal Medicine found that men diagnosed with localized prostate cancer were more likely to be treated with proton therapy if the technology was available nearby. The study evaluated the treatment choices of nearly 20,000 men living inside and outside the regional market for Loma Linda University. Nearly 9% of the patients living within the referral region received PRT, compared to less than 2% of patients living outside the region.

RNCOS, in its latest research, “US Proton Therapy Market Analysis to 2017”, had also found that cancer patients deemed medically eligible for proton therapy, had to travel long distances to avail the therapy as few centers were present throughout the US. As of 2012, only 10 states had a proton therapy center. These centers together catered to just approximately 5% of the total cancer patient population that needed this therapy.

Besides, even five years down the lane, only 15 states are expected to have a proton therapy center, leaving behind huge chunks of cancer patient pool, deemed medically in need of proton therapy. Healthcare entities, both public and private need to take a note of this and find viable solutions to this looming problem.

RNCOS’s research, smartly depicted in a 30 slide presentation, provides key market dynamics and actionable insights that will help the players in identifying key areas for growth. The report provides a thorough opportunity assessment and clearly states the number of potential patients for proton therapy along with their state-wise breakup to help players decide in where to setup a new proton therapy center.

Further, to help the reader in understanding the various characteristics involved in setting up a proton therapy center, the report describes the different components and diverse aspects involved with a proton therapy center. Moreover, it also gives a glimpse of the investment required for establishing a proton therapy center based on different treatment room models. The report also comes up with upcoming trends, such as kind of treatment room model, types of proton accelerators being installed, etc. to provide insights into the direction that the industry is taking on a whole, such that the players can adapt and design suitable business strategies.

This all-inclusive study of the US proton therapy market by RNCOS experts clearly describes important aspects of market like the current market size, forecasts, along with various drivers, challenges and trends, making it a must read for Consultants and Companies in/planning to get in the market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM465.htm

Some of our Related Reports are:

- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)
- US Cardiac Device Market Analysis (http://www.rncos.com/Report/IM441.htm)
- US Clinical Laboratory Testing Market Assessment (http://www.rncos.com/Report/IM442.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

NONE

B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

This release was published on openPR.